Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celldex Therapeutics (CLDX) Treasury Shares (2016 - 2019)

Celldex Therapeutics (CLDX) has 9 years of Treasury Shares data on record, last reported at $1110.0 in Q4 2019.

  • For Q4 2019, Treasury Shares fell 68.75% year-over-year to $1110.0; the TTM value through Dec 2019 reached $1110.0, down 68.75%, while the annual FY2019 figure was $1110.0, 68.75% down from the prior year.
  • Treasury Shares reached $1110.0 in Q4 2019 per CLDX's latest filing, down from $3552.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $50000.0 in Q4 2016 and bottomed at $1110.0 in Q4 2019.
  • Average Treasury Shares over 5 years is $16121.4, with a median of $6445.0 recorded in 2017.
  • Peak YoY movement for Treasury Shares: surged 178.57% in 2015, then crashed 87.11% in 2017.
  • A 5-year view of Treasury Shares shows it stood at $19500.0 in 2015, then surged by 156.41% to $50000.0 in 2016, then plummeted by 87.11% to $6445.0 in 2017, then plummeted by 44.89% to $3552.0 in 2018, then plummeted by 68.75% to $1110.0 in 2019.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $1110.0 in Q4 2019, $3552.0 in Q4 2018, and $6445.0 in Q4 2017.